For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Cosmo Technologies Limited

Calculating rank

USPTO Granted Patents = 50

% Expired Patents = 30.0

CIPO Patents = 4

EPO Patents = 17

Trademarks = 14

Forward Citations = 320

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Roberto Villa (32 out of 33 patents)

Mauro Ajani (31 out of 44 patents)

Massimo Pedrani (22 out of 23 patents)

4. Lorenzo Fossati (22 out of 23 patents)

5. Luigi Moro (17 out of 32 patents)

6. Luigi Maria Longo (12 out of 16 patents)

7. Alessandro Repici (12 out of 12 patents)

8. Enrico Frimonti (9 out of 9 patents)

9. Giuseppe Celasco (8 out of 8 patents)

10. Mara Gerloni (6 out of 7 patents)

11. Roberta Bozzella (4 out of 4 patents)

12. Mauro Ajani Fossati (1 out of 1 patent)

13. Franca Ferrari (1 out of 2 patents)

14. Giuseppina Sandri (1 out of 1 patent)

15. Silvia Rossi (1 out of 1 patent)

Core Competencies:

Oral Rifamycin

Liquid Delivery

Cortexolone

Tumor Treatment

Emulsions

Microemulsions

Controlled Release

Taste Masking

Diagnostic Procedures

Pharmaceutical Compositions

50 patents: Sort by Forward Citations

1. 12036316 - Oral rifamycin SV compositions (2024-07-16),

2. 12011483 - Liquid delivery composition (2024-06-18),

3. 11986484 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2024-05-21),

4. 11712443 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2023-08-01),

5. 11564883 - Oral rifamycin SV compositions (2023-01-31),

6. 11123460 - Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection (2021-09-21),

7. 10993949 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2021-05-04),

8. 10925978 - Liquid composition in the form of emulsion or microemulsion for rectal administration containing at least one dye, and its use in a diagnostic endoscopic procedure of sigmoid colon and/or rectum (2021-02-23),

9. 10849979 - Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection (2020-12-01),

10. 10660858 - Controlled release and taste masking oral pharmaceutical composition (2020-05-26),

11. 10646497 - 17α-monoesters and 17α,21-diesters of cortexolone for use in the treatment of tumors (2020-05-12),

12. 10413611 - Emulsions or microemulsions for use in endoscopic mucosal resectioning and/or endoscopic submucosal dissection (2019-09-17),

13. 10307375 - Controlled release and taste masking oral pharmaceutical composition (2019-06-04),

14. 10265420 - Solid composition for the oral administration of dyes and diagnostic use thereof (2019-04-23),

15. 10231980 - Cortexolone 17alpha-benzoate for use in the treatment of tumours (2019-03-19),

Company Overview

Cosmo Technologies Limited, based in Dublin, Ireland, specializes in the development of innovative pharmaceutical compositions. The company focuses on advanced drug delivery systems, particularly in the areas of oral rifamycin formulations and liquid delivery methods. Their expertise extends to the formulation of cortexolone and tumor treatment solutions, utilizing emulsions and microemulsions for enhanced therapeutic efficacy. Cosmo Technologies is committed to improving patient outcomes through controlled release technologies and effective taste masking strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

50 Patents

#39 in Dublin

#65 in Ireland

#14,028 in the World

Dublin, Ireland

Cosmo Technologies Limited

Forward Citations = 320

17 inventors:

Roberto Villa (32 out of 33 patents)

Mauro Ajani (31 out of 44 patents)

Massimo Pedrani (22 out of 23 patents)

4. Lorenzo Fossati (22 out of 23 patents)

5. Luigi Moro (17 out of 32 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cosmo Technologies Limited. Retrieved from https://idiyas.com/company/cosmo-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…